From: A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker
Cohort
Copper Gluconate
Disulfiram
1
2 mga
250 mg
2
4 mg
3
6 mg
4
8 mg